Insulin Signaling and Glucose Metabolism

Canonical source: hsa04910

Pathway Overview

Insulin signaling regulates glucose uptake, glycogen synthesis, lipogenesis, and gene expression. Insulin binds the insulin receptor, activating IRS-PI3K-AKT cascade; AKT phosphorylates substrates including GSK3 and FoxO. In pancreatic beta cells, glucose stimulates insulin secretion; TCF7L2 regulates proglucagon processing and incretin response. Defects cause insulin resistance and type 2 diabetes. FTO and MC4R influence energy balance and adiposity, which drive insulin resistance. Diet quality and obesity are major environmental modulators. TCF7L2 variants impair beta cell function and incretin response; FTO affects hypothalamic energy sensing.

Environmental Triggers

ExposureTrigger type
diet-qualityRefined carbohydrates and saturated fat promote insulin resistance
obesity-exposureAdiposity drives systemic insulin resistance and beta cell exhaustion
psychosocial-stressCortisol promotes gluconeogenesis and antagonizes insulin

Genetic Modulation Points

Key genes

  • tcf7l2— Transcription factor; regulates Wnt signaling and beta cell function; variants impair insulin secretion and incretin response
  • fto— Energy balance regulation; hypothalamic expression; variants influence adiposity and T2D risk via obesity
  • mc4r— Melanocortin receptor; appetite and energy expenditure; modulates obesity and insulin resistance

Regulatory checkpoints

  • Beta cell insulin secretion— tcf7l2Therapeutic target
  • Hypothalamic energy sensing— fto, mc4rTherapeutic target

Tissue Specificity

pancreas— Beta cells; insulin synthesis and secretion
liver— Glycogen synthesis; gluconeogenesis regulation
adipose tissue— Glucose uptake; lipogenesis

Disease Relevance

Linked diseases

  • type-2-diabetes— Core pathogenic pathway; insulin resistance and beta cell dysfunction
  • obesity— Obesity drives insulin resistance; FTO and MC4R are major obesity genes

Linked exposures

  • diet-quality— Diet directly modulates insulin sensitivity and beta cell demand
  • obesity-exposure— Adiposity is primary driver of insulin resistance

Pathway Diagram

Pathway diagram placeholder. A visual representation of this pathway will be integrated when available.

Evidence Nodes

Evidence for this pathway is derived from:

  • 3 environmental trigger(s)
  • 3 key gene(s)
  • 2 linked disease(s)
  • 2 linked exposure(s)

References

  1. 1.Grant SF, et al. (2006). TCF7L2 and type 2 diabetes. Nature Genetics. doi:10.1038/ng1842
  2. 2.Claussnitzer M, et al. (2015). FTO and energy homeostasis. New England Journal of Medicine. doi:10.1056/NEJMra1500792
  3. 3.Loos RJF, et al. (2020). MC4R in obesity and metabolic disease. Nature Reviews Endocrinology. doi:10.1038/s41574-020-0341-8
  4. 4.Cornelis MC, Hu FB (2012). Gene-environment interaction in type 2 diabetes. Current Diabetes Reports. doi:10.1007/s11892-012-0313-4